Haemonetics Corp
NYSE:HAE

Watchlist Manager
Haemonetics Corp Logo
Haemonetics Corp
NYSE:HAE
Watchlist
Price: 94 USD 2.42%
Market Cap: 4.8B USD
Have any thoughts about
Haemonetics Corp?
Write Note

Haemonetics Corp
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Haemonetics Corp
Operating Expenses Peer Comparison

Comparables:
XRAY
ICUI
ALGN
LNTH
MMSI

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Haemonetics Corp
NYSE:HAE
Operating Expenses
-$520.2m
CAGR 3-Years
-12%
CAGR 5-Years
-11%
CAGR 10-Years
-4%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Operating Expenses
-$1.8B
CAGR 3-Years
-1%
CAGR 5-Years
-1%
CAGR 10-Years
-4%
ICU Medical Inc
NASDAQ:ICUI
Operating Expenses
-$689.3m
CAGR 3-Years
-26%
CAGR 5-Years
-17%
CAGR 10-Years
-21%
Align Technology Inc
NASDAQ:ALGN
Operating Expenses
-$2.1B
CAGR 3-Years
-5%
CAGR 5-Years
-12%
CAGR 10-Years
-19%
Lantheus Holdings Inc
NASDAQ:LNTH
Operating Expenses
-$495.3m
CAGR 3-Years
-33%
CAGR 5-Years
-33%
CAGR 10-Years
-21%
Merit Medical Systems Inc
NASDAQ:MMSI
Operating Expenses
-$468.1m
CAGR 3-Years
-5%
CAGR 5-Years
-4%
CAGR 10-Years
-10%

See Also

What is Haemonetics Corp's Operating Expenses?
Operating Expenses
-520.2m USD

Based on the financial report for Sep 28, 2024, Haemonetics Corp's Operating Expenses amounts to -520.2m USD.

What is Haemonetics Corp's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-4%

Over the last year, the Operating Expenses growth was -11%. The average annual Operating Expenses growth rates for Haemonetics Corp have been -12% over the past three years , -11% over the past five years , and -4% over the past ten years .

Back to Top